OncoSenX
PrivateLast Round
VC Round
Aug 5, 2021
Total Funding Raised
$5.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoSenX is a biotechnology company that develops transient gene therapies designed to treat cancer. The company's therapy delivers a program that induces apoptosis in cancerous cells using a plasmid DNA delivered with a proteo-lipid vehicle that selectively kills cancerous cells based on their transcriptional activity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoSenX Comparables
Compare OncoSenX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oisín Biotechnologies | 79% | |
| Entos Pharmaceuticals | 76% | |
| BreezeBio | 68% |
OncoSenX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 5, 2021 | ||||
| Series A | Apr 1, 2020 | ||||
| Pre Seed | Jul 8, 2019 | ||||
| Seed | Mar 14, 2019 |
Key People
Founding team and executive leadership
OncoSenX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helios Capital | VC Round |
| Althea | Pre Seed |
| Methuselah Foundation | VC Round, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- May 18, 2026
Monthly visitors increased 105% MoM.
OncoSenX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OncoSenX's valuation, stock price, and market status.
Is OncoSenX a public or private company?
OncoSenX is a private company.
What is the current stock price of OncoSenX?
OncoSenX is a private company with no public stock price. No recent secondary market data is available.
How much is OncoSenX worth (valuation)?
Valuation information for OncoSenX is not publicly available.
Can I buy OncoSenX stock?
OncoSenX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OncoSenX's last funding round?
OncoSenX's most recent funding round was VC Round on August 5, 2021.
Who are the main investors in OncoSenX?
Key investors in OncoSenX include Methuselah Foundation.
Will OncoSenX IPO soon?
No public IPO plans have been announced for OncoSenX.
How can I track OncoSenX secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoSenX's secondary market activity and sign up for updates.